Issuer · CIK 0001652130
NTLA — Intellia Therapeutics, Inc.
Recent filings
- Jul 24, 2026·Form 4·Sell$91.2K
NTLA/Intellia Therapeutics, Inc.
Dulac Edward J III · EVP, Chief Financial Officer
Mechanical filing
AI thesis skipped - Jul 6, 2026·Form 4·Sell$84.2K
NTLA/Intellia Therapeutics, Inc.
Dulac Edward J III · EVP, Chief Financial Officer
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
Verwiel Frank · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
Keresty Georgia · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
GOODMAN JESSE · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
Goff Brian · Chief Executive Officer
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
Cohen Fred E · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
NTLA/Intellia Therapeutics, Inc.
CHASE WILLIAM J · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other$0
NTLA/Intellia Therapeutics, Inc.
Bhanji Muna · director
Mechanical filing
AI thesis skipped